CAD (NASDAQ:ICAD – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Friday. iCAD Trading Down 15.1 % ...

A casual stroll down San Francisco's Union Street in early January led 38-year-old Jenna Williams to a life-saving discovery.

Eyeing an expected leap in demand for contrast media—used in X-rays, CT scans and more—GE HealthCare is upping its stake in the Emerald Isle. | GE HealthCare is pumping $138 million into its ...

CAD (NASDAQ:ICAD) (market cap: $85.26M), a leader in AI-powered breast cancer detection, reported its third-quarter 2024 financial results, demonstrating a 4% year-over-year increase in revenue to $4.